Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Tables)

v3.20.2
Stockholders’ Equity (Tables)
9 Months Ended
Sep. 30, 2020
Stockholders' Equity Note [Abstract]  
Schedule of fair value of options granted
          Weighted     Weighted        
          Average     Average        
    Number of     Exercise     Remaining     Intrinsic  
    Options     Price     Term (Yrs)     Value  
                         
Outstanding, January 1, 2020     2,480,000     $ 4.34       9.86     $
        -
 
Granted     200,000       2.15                  
Exercised    
-
     
-
                 
Expired    
-
     
-
                 
Forfeited     (250,000 )     4.47                  
Outstanding, September 30, 2020     2,430,000     $ 4.15       9.15     $
-
 
                                 
Exercisable, September 30, 2020     100,000     $ 5.66       2.38     $
-
 

 

Schedule of options outstanding and exercisable
Options Outstanding     Options Exercisable  
            Weighted        
      Outstanding     Average     Exercisable  
Exercise     Number of     Remaining Life     Number of  
Price     Options     In Years     Options  
2.11       80,000      
-
     
-
 
$ 2.17       120,000      
-
     
-
 
$ 4.09       1,890,000      
-
     
-
 
$ 5.66       340,000       2.38       100,000  
          2,430,000               100,000  

 

Schedule of fair value of options granted
Risk free interest rate     0.55% – 0.69 %
Expected term (years)     6.25  
Expected volatility     38 %
Expected dividends     0.00 %

Schedule of non-vested restricted stock activity
    Number of
Restricted
Stock
    Weighted
Average
Grant Date
Fair Value
 
Non-vested balance, January 1, 2020     80,393     $ 5.66  
Granted     199,143       2.02  
Vested     (80,393 )     5.66  
Forfeited    
-
     
-
 
Non-vested balance, September 30, 2020     199,143     $ 2.02  

 

Schedule of warrant activity
    Number of
Warrants
    Weighted
Average
Exercise
Price
    Weighted
Average
Remaining
Life in Years
    Intrinsic
Value
 
Outstanding, January 1, 2020     18,637,003     $ 11.50       4.6     $
     -
 
Issued     1,454,546       4.13                  
Exercised    
-
     
-
                 
Cancelled    
-
     
-
                 
Outstanding, September 30, 2020     20,091,549     $ 10.97       3.9     $
-
 
                                 
Exercisable, September 30, 2020     20,091,549     $ 10.97       3.9     $
-
 

 

Schedule of warrants outstanding and exercisable
Warrants Outstanding     Warrants Exercisable  
Exercise Price     Exercisable Into   Outstanding
Number of
Warrants
    Weighted
Average
Remaining
Life in Years
    Exercisable
Number of
Warrants
 
$ 11.50     Common Stock     18,637,003     3.9       18,637,003  
$ 4.13     Common Stock     1,454,546     4.7       1,454,546  
              20,091,549             20,091,549